PRISCILLA WONG: Open Payments
NPI 1588210660 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 32 payments from 8 companies in 2025. Trend: 2023 $1,218 · 2024 $1,185 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $398 |
| Lilly USA, LLC | 7 | $348 |
| Novo Nordisk Inc | 10 | $258 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Abbott Laboratories | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Ozempic, MOUNJARO, FARXIGA, BREZTRI, KISUNLA, AIRSUPRA, JARDIANCE, GEMTESA.
Industry payments across TX — which companies pay providers there.
